Nicholas Brownstone, MD, a dermatology resident at Temple University Hospital, penned an article for the Dermatology Times about psoriasis therapies that will shape the treatment landscape in 2024 and beyond.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn MoreNicholas Brownstone, MD, a dermatology resident at Temple University Hospital, penned an article for the Dermatology Times about psoriasis therapies that will shape the treatment landscape in 2024 and beyond.